A Clinical Trial of Parkinson's Disease Treatment by HiPSCs Derived Dopaminergic Neural Precursor Cells
NCT06145711
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Parkinson's Disease
Interventions
OTHER:
hiPSC-DAP
Sponsor
Shanghai East Hospital